Ana Afonso, Gil Marques, Ana Gonçalves, Pedro Barroso, Antonio Gonzalez, Hugo Rodrigues, Maria José Ferreira
{"title":"A terapêutica antitrombótica: atual e em desenvolvimento","authors":"Ana Afonso, Gil Marques, Ana Gonçalves, Pedro Barroso, Antonio Gonzalez, Hugo Rodrigues, Maria José Ferreira","doi":"10.1016/j.ancv.2016.08.001","DOIUrl":null,"url":null,"abstract":"<div><p>Thrombosis is one of the major causes of death worldwide. Continous increase in the knowledge about the pathophysiological changes associated with thrombosis led to the development of effective therapies (anti‐platelet, anticoagulant and fibrinolytics) for the prevention and treatment of the thromboembolic disease.</p><p>However, better understanding of the underlying processes is still crucial for the development of more effective and safer antithrombotic drugs.</p><p>The aim of this review is summarize the current treatment, as well as the new agentes and to highlight their proven or possible role in Vascular Surgery.</p></div>","PeriodicalId":30341,"journal":{"name":"Angiologia e Cirurgia Vascular","volume":"12 3","pages":"Pages 170-179"},"PeriodicalIF":0.0000,"publicationDate":"2016-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.ancv.2016.08.001","citationCount":"4","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Angiologia e Cirurgia Vascular","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1646706X16300581","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 4
Abstract
Thrombosis is one of the major causes of death worldwide. Continous increase in the knowledge about the pathophysiological changes associated with thrombosis led to the development of effective therapies (anti‐platelet, anticoagulant and fibrinolytics) for the prevention and treatment of the thromboembolic disease.
However, better understanding of the underlying processes is still crucial for the development of more effective and safer antithrombotic drugs.
The aim of this review is summarize the current treatment, as well as the new agentes and to highlight their proven or possible role in Vascular Surgery.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
